Welcome to our dedicated page for ASTROTECH SEC filings (Ticker: ASTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astrotech Corporation filings document an instrumentation company organized around subsidiaries applying mass spectrometry and gas chromatography to security screening, narcotics detection, agriculture processing, industrial process control, breath analysis, and environmental testing. Results-related 8-K reports include operating updates for product lines such as TRACER 1000 and EN-SCAN.
The filing record also covers security-holder rights under the company's rights agreement, annual meeting voting matters, executive compensation and governance disclosures in proxy materials, officer changes, consulting arrangements, and transaction-related compensation plans. These disclosures describe ASTC's capital structure, board oversight, compensation framework, and material-event reporting obligations.
ASTROTECH Corp reports that Matthew Kreps is a director subject to insider ownership reporting. His initial ownership statement lists no reportable ASTROTECH Corp securities, no derivative positions, and no insider transactions, and he is not identified as a ten percent owner.
ASTROTECH Corp ownership update: Skylark Partners I filed an amended Schedule 13G/A reporting 0 shares beneficially owned (0%) as of 06/30/2026. The filing also states the filer has sole power to vote 100 shares and sole power to dispose of 100 shares. The form is signed by John Porter as Manager of Skylark Partners Management, LLC.
Astrotech Corporation registers a shelf offering of securities with an aggregate initial offering price of $200,000,000 under a shelf registration statement dated (subject to completion). The shelf permits sales from time to time of common stock, preferred stock, debt securities, warrants and units in one or more offerings.
Each specific offering will be described in a prospectus supplement that will state the class, amount, price and net proceeds treatment; the prospectus notes that proceeds treatment and distribution methods will be set forth in those supplements. The prospectus also discloses that the company is a smaller reporting company, lists 2,009,050 shares outstanding as of June 26, 2026, and describes existing capital structure items including Series D preferred stock, issued warrants (all expired) and outstanding options.
Astrotech Corporation’s board has authorized management to pursue a potential sale process for its 1st Detect Corporation subsidiary, which develops the TRACER 1000 explosives and narcotics trace detection platform. The company is evaluating a sale to raise additional capital for its previously announced lunar mining initiative.
The press release highlights multiple regulatory and operational milestones for TRACER 1000, including TSA and European certifications and a U.S. Department of Homeland Security development award, which management believes have increased 1st Detect’s strategic value. The company cautions that any sale is uncertain and subject to market, regulatory, and execution risks.
Astrotech Corporation entered into an at-the-market offering agreement that allows it to sell shares of its common stock with an aggregate offering price of up to $24,492,819 through H.C. Wainwright & Co., LLC. Sales may be made from time to time under the company’s effective Form S-3 shelf registration and a June 2, 2026 prospectus supplement.
Wainwright will act as sales agent and receive a 3.0% commission on the aggregate gross proceeds from each sale. Astrotech is not required to sell any shares, and the program will end when all authorized shares are sold or the agreement is terminated.
Astrotech Corporation is registering an at-the-market offering to sell up to $24,492,819 of its common stock through H.C. Wainwright & Co., LLC as sales agent. The offering permits sales from time to time on the Nasdaq Capital Market at market prices under an Offering Agreement dated June 2, 2026.
The prospectus supplement cites a Sales Agent commission of 3.0%, an example issuance of 538,304 shares at an assumed price of $45.50 (resulting in up to 2,337,603 shares outstanding in that example), and a public float of approximately $73,478,456 based on 1,799,299 shares outstanding as of May 29, 2026.
Wilkinson Tom reported acquisition or exercise transactions in this Form 4 filing.
ASTROTECH Corp director Tom Wilkinson received a grant of 6,006 shares of restricted common stock. The award was made at a price of $0.00 per share and brought his direct holdings to 29,868 shares. All of the restricted shares vested immediately on the grant date.
Winn Charles Arch reported acquisition or exercise transactions in this Form 4 filing.
ASTROTECH Corp director Winn Charles Arch received a grant of 6,006 shares of common stock as equity compensation. The shares were granted as restricted stock under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan and vested in full on the grant date. Following this award, Arch directly holds 9,895 shares of common stock, including 485 shares held in his IRA.
Halinski John William reported acquisition or exercise transactions in this Form 4 filing.
ASTROTECH Corp director John William Halinski received a grant of 6,006 shares of restricted common stock on May 14, 2025 under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. The award vested in full immediately, bringing his directly held common shares to 9,006 after the grant.